NCT03179787View on ClinicalTrials.gov

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

CompletedOBSERVATIONAL
Enrollment

528

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

March 17, 2020

Study Completion Date

July 6, 2020

Conditions
Autism
Interventions
DRUG

Aripiprazole oral product

oral administration of aripiprazole

Trial Locations (1)

Unknown

Otsuka Pharmaceutical Co., Ltd., Tokyo

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY